EASSA Study Group, c/o CEESA, 168, Av. de Tervueren, Brussels, Belgium.
Vetoquinol S.A., Lure, France.
J Antimicrob Chemother. 2022 Nov 28;77(12):3301-3311. doi: 10.1093/jac/dkac318.
To describe the susceptibility of Escherichia coli to medically important antibiotics, collected over four periods (2004-2006, 2008-2009, 2013-2014, 2017-2018), from food-producing animals at slaughter.
Intestinal contents from cattle, pigs and broilers were randomly sampled (5-6 countries/host; ≥4 abattoirs/country; one sample/animal/farm) for isolation of Escherichia coli; antimicrobial susceptibilities were centrally determined by CLSI agar dilution. Clinical breakpoints (CLSI) and epidemiological cut-off values (EUCAST) were applied for data interpretation.
In total, 10 613 E. coli strains were recovered. In broilers, resistance percentages were the lowest (P ≤ 0.01) in the latest time period. A significant decrease in MDR over time was also observed for broilers and a tendency for a decrease for pigs. Resistance to meropenem and tigecycline was absent, and resistance to azithromycin was 0.2%-2.0%. Also, low resistance to third-generation cephalosporins (1.1%-7.4%) was detected in broilers. Resistance to colistin varied between 0.1%-4.8%. E. coli from broilers showed high resistance to ciprofloxacin (7.3%-23.3%), whereas for cattle and pigs this was 0.2%-2.5%. Low/moderate resistance to chloramphenicol (9.3%-21.3%) and gentamicin (0.9%-7.0%) was observed in pigs and broilers. The highest resistance was noted for ampicillin (32.7%-65.3%), tetracycline (41.3%-67.5%), trimethoprim (32.0%-35.7%) and trimethoprim/sulfamethoxazole (27.5%-49.7%) from pigs and broilers, with marked country differences. MDR peaked in pigs and broilers with 24 and 26 phenotypes, with 21.9%-26.2% and 18.7%-34.1% resistance, respectively.
In this pan-EU survey antibiotic susceptibility of commensal E. coli varied largely between antibiotics, animal species and countries. Resistance to critically important antibiotics for human medicine was absent or low, except for ciprofloxacin in broilers and ampicillin in pigs and broilers.
描述屠宰食用动物中产肠杆菌对重要医学抗生素的敏感性,该研究数据来源于四个时期(2004-2006 年、2008-2009 年、2013-2014 年、2017-2018 年)的采集结果。
从牛、猪和肉鸡的肠道内容物中随机取样(每个国家/宿主 5-6 个;每个国家 4 个以上屠宰场;每个动物/农场 1 个样本),以分离产肠杆菌;采用 CLSI 琼脂稀释法对其进行抗菌药物敏感性检测。采用 CLSI 临床折点和 EUCAST 流行病学折点进行数据解读。
共分离出 10613 株产肠杆菌。在肉鸡中,最新时期的耐药率最低(P≤0.01)。此外,肉鸡中产肠杆菌对多重耐药性(MDR)的减少也具有显著的时间趋势,且猪的 MDR 也有减少的趋势。产肠杆菌对美罗培南和替加环素具有耐药性,对阿奇霉素的耐药率为 0.2%-2.0%。此外,在肉鸡中还检测到第三代头孢菌素的耐药率较低(1.1%-7.4%)。产肠杆菌对黏菌素的耐药率在 0.1%-4.8%之间。与牛和猪相比,肉鸡中产肠杆菌对环丙沙星的耐药率(7.3%-23.3%)较高。猪和肉鸡中产肠杆菌对氯霉素(9.3%-21.3%)和庆大霉素(0.9%-7.0%)的耐药率较低/中等。产肠杆菌对氨苄西林(32.7%-65.3%)、四环素(41.3%-67.5%)、甲氧苄啶(32.0%-35.7%)和甲氧苄啶/磺胺甲噁唑(27.5%-49.7%)的耐药性最高,而且这些耐药性在不同国家之间存在显著差异。猪和肉鸡的 MDR 最高,分别为 24 种和 26 种表型,耐药率分别为 21.9%-26.2%和 18.7%-34.1%。
在这项全欧盟调查中,共生产肠杆菌对抗生素的敏感性因抗生素、动物种类和国家的不同而有很大差异。除了肉鸡中环丙沙星和猪与肉鸡中氨苄西林的耐药性外,产肠杆菌对人类医学中重要的抗生素的耐药性为零或较低。